The patient, their doctor, the regulator and the profit maker: conflicts and possible solutions.
The dilemmas and conflicts between industry, who develop and market antibiotics and the regulators who are responsible for regulating their use to preserve efficacy are explored. Despite regulations, the industry remains profitable and should concentrate more on development of innovative products which readily gain market share without excessive marketing. Various aspects of regulations are discussed as they influence the prescriber and the patient.
Monnet
D L
DL
Antimicrobial Resistance Surveillance Unit, Statens Serum Institut, Copenhagen, Denmark. dom@ssi.dk
Sørensen
T L
TL
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003718:Denmark; D004345:Drug Industry / Q000191:economics* / Q000331:legislation & jurisprudence; D004363:Drug Utilization / Q000592:standards*; D004335:Drug and Narcotic Control; D006801:Humans; D010353:Patient Education as Topic; D011320:Primary Health Care
D000900:Anti-Bacterial Agents